Alliqua, Inc., a biomedical products company, through its subsidiaries, focuses on the development and manufacture of proprietary technologies in the fields of drug delivery, advanced wound care, and liver health preservation. The company intends to develop, manufacture, and market active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform. It also manufactures custom hydrogels that are used for transdermal drug delivery, wound care, medical diagnostics, and cosmetics. In addition, Alliqua offers HepaMate, an extracorporeal cell based bioartificial liver system to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the severe forms of liver failure.
Quote | Alliqua BioMedical Inc. (NASDAQ:ALQA)
|Last Trade Date Time:||12/31/1969 07:00:00 pm|
News | Alliqua BioMedical Inc. (NASDAQ:ALQA)
Thinly traded nano cap Alliqua BioMedical (NASDAQ: ALQA ) is up 28% premarket on light volume on the heels of its agreement to execute a reverse merger with privately held Adynxx . More news on: Alliqua BioMedical, Inc., Healthcare stocks news, Stocks on the move, Merger &am...
Message Board Posts | Alliqua BioMedical Inc. (NASDAQ:ALQA)
|Good morning sir, any clue as to what||Swampdude||investorshub||10/23/2019 11:36:12 AM|
|Anybody know what's going on with this ticker?||Swampdude||investorshub||10/21/2019 2:31:06 PM|
|I've been in about a month. Bought at||pauljack13||investorshub||04/11/2019 11:34:55 PM|
|in for a few||yankees18||investorshub||04/11/2019 9:25:24 PM|
|$ALQA: Massive Explosion Within Days?||stephenbolder||investorshub||03/23/2019 2:17:11 AM|
Alliqua BioMedical Inc. Company Name:
ALQA Stock Symbol:
Alliqua BioMedical Inc. Website:
LANGHORNE, Pa., April 11, 2019 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) announced today that its Board of Directors has declared a special cash dividend of $1.05 for each share of common stock outstanding as of the close of business on April 22, 2019 (the “Record D...